3,106
Views
10
CrossRef citations to date
0
Altmetric
Review Article

2. How is the economic assessment of vaccines performed today?

Article: 1335163 | Received 02 May 2017, Accepted 22 May 2017, Published online: 31 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tatenda Yemeke, Hui-Han Chen & Sachiko Ozawa. (2023) Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance. Human Vaccines & Immunotherapeutics 19:1.
Read now
Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge Gomez, Lijoy Varghese & Sharon Zhang. (2020) How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future. Journal of Market Access & Health Policy 8:1.
Read now
Roy K. Philip, Katie Attwell, Thomas Breuer, Alberta Di Pasquale & Pier Luigi Lopalco. (2018) Life-course immunization as a gateway to health. Expert Review of Vaccines 17:10, pages 851-864.
Read now

Articles from other publishers (7)

Ahmed Mohy, Nicola Page, Welekazi Boyce & Jorge A. Gomez. (2023) Economic Evaluation of Rotavirus Vaccination in Children Aged Under Five Years in South Africa. Clinical Drug Investigation 43:11, pages 851-863.
Crossref
Ellen Rafferty, Laura Reifferscheid, Ali Assi & Shannon E. MacDonald. (2022) Using Health Economics to Inform Immunization Policy Across All Levels of Government. PharmacoEconomics - Open 6:5, pages 631-635.
Crossref
Madison C. Silver, Peter J. Neumann, Siyu Ma, David D. Kim, Joshua T. Cohen, Mawuli Nyaku, Craig Roberts, Anushua Sinha & Daniel A. Ollendorf. (2021) Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines. Vaccine 39:46, pages 6727-6734.
Crossref
Valérie Laigle, Maarten J Postma, Mira Pavlovic, Chiara Cadeddu, Ekkehard Beck, Anna Kapusniak & Mondher Toumi. (2021) Vaccine market access pathways in the EU27 and the United Kingdom − analysis and recommendations for improvements. Vaccine 39:39, pages 5706-5718.
Crossref
Yasuko AITOKU. (2021) 3.Value Assessment of Vaccines and Drugs: Learnings from COVID-19 Pandemic3.ワクチン・治療薬の価値評価:COVID-19 パンデミックからの学び. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 26:1, pages 71-78.
Crossref
Baudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, Sandra Talbird, Katherine Hicks, Justin Carrico & Philip O. Buck. (2019) Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project. Applied Health Economics and Health Policy 18:4, pages 519-531.
Crossref
Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza & Rino Rappuoli. (2020) Vaccines Against Antimicrobial Resistance. Frontiers in Immunology 11.
Crossref